Researching Effective Strategies to Prevent Opioid Death (RESPOND)BSBruce SchackmanSMSean M. MurphyYBYuhua BaoMPINational Institute on Drug Abuse · 2018–2028 · via Boston Medical Center (Corporation)Abstract & 15 publicationsR01DA046527-05Active
Pretargeted Radioimmunotherapy Based on Bioorthogonal Click ChemistryBZBrian ZeglisNational Cancer Institute · 2014–2018Abstract & 2 publicationsR00CA178205-04
Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancerBSBrett S. CarverCLCharles L. SawyersYCYu ChenMPINational Cancer Institute · 2017–2023Abstract & 13 publicationsU54CA224079-04
Role of NadD in Mycobacterium tuberculosis proteostasisBSBen S GoldNational Institute of Allergy and Infectious Diseases · 2021–2024Abstract & 1 publicationR21AI159572-02
Evaluation of hits and leads for TBDA priority targets - INV100447CFCarl F. NathanBSBen S GoldBill & Melinda Gates Foundation · 2026–2027AbstractINV-100447Ending soon
Genome-Wide Study to Identify SNPs and CNPs Associated with Radiation InjuryBRBarry RosensteinNational Cancer Institute · 2009–2014AbstractR01CA134444-04
Blood-brain barrier effects of accelerated transcranial magnetic stimulation in depressionEGEric GoldwaserBrain & Behavior Research Foundation · 2024–2026BBRF 231473-02Ending soon
Deconstructing Disparities in Lupus PregnanciesBYBella Yogesh MehtaNational Institute of Arthritis and Musculoskeletal and Skin Diseases · 2024–2029Abstract & 1 publicationK23AR082991-03Active
Enterococcus faecium virulence: A molecular and therapeutic approachCACesar Augusto AriasNational Institute of Allergy and Infectious Diseases · 2008–2012AbstractR00AI072961-02S1
Molecular Mechanisms Of Daptomycin Resistance In EnterococciCACesar Augusto AriasNational Institute of Allergy and Infectious Diseases · 2011–2017AbstractR01AI093749-05
Molecular basis of the cefazolin inoculum effectCACesar Augusto AriasNational Institute of Allergy and Infectious Diseases · 2018–2020AbstractR21AI143229-02
Texas Medical Center Training Program in Antimicrobial ResistanceCACesar Augusto AriasNational Institute of Allergy and Infectious Diseases · 2019–2024AbstractT32AI141349-02
Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)CACesar Augusto AriasNational Institute of Allergy and Infectious Diseases · 2024–2029AbstractT32AI179595-03Active
Treatment of APOE4-associated Cognitive Decline in Parkinson's Disease by an Adeno-associated Virus Coding for the Combined APOE2 and APOE-Christchurch VariantCGCaner GunaydinRGRonald G CrystalMichael J. Fox Foundation for Parkinson's Research · 2025–2027MJFF 251995-01Active
Vitreo-retinal disease imaging with 3D annular-array ultrasoundJKJeffrey KetterlingCHCameron HoerigJMJonathan MamouNational Institute of Biomedical Imaging and Bioengineering · 2022–20258 publicationsR01EB032082-02Recently ended
Quantitative Ultrasound for Interstitial Lung DiseasesJMJonathan MamouCHCameron HoerigNational Heart, Lung, and Blood Institute · 2024–2028 · via North Carolina State UniversityAbstractR01HL175513-01Active
Subject-Specific Mechanisms of Knee LaxityCWCarl W. ImhauserNational Institute of Arthritis and Musculoskeletal and Skin Diseases · 2018–2021AbstractR21AR073388-02
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.CAChristopher Austin KlebanoffNational Cancer Institute · 2021–2028AbstractR37CA259177-06Active
Objective Measures of Social Interactions via Wearable CamerasRMRebecca M. JonesCLCatherine LordSimons Foundation · 2015–2018 · via Georgia Institute of Technology383667
3/3-Effectiveness Trial of the Early Social Interaction (ESI) Model using Mobile Technology for Toddlers with Autism Identified from Early Screening in Primary CareCLCatherine LordNational Institute of Mental Health · 2021–2026AbstractR01MH127120-03Ending soon